相关实验视频

Updated: Jul 19, 2025

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

患者中Cenobamate高度耐火的焦点:一个追溯的现实世界的研究

Álvaro Beltrán-Corbellini¹, María Romeral-Jiménez², Pablo Mayo²

¹Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain.

|August 7, 2023

概括

塞诺巴有效降低了高度耐火的焦点患者的发作频率和强度. 该疗法在现实临床实践中显示出良好的保留率和可管理的安全性概况.

科学领域:

神经学神经学
发病学 (Epileptology) 是一个专业的学科.
药理学药理学是指药理学的学科.

背景情况:

焦点是一种具有挑战性的神经系统疾病,特别是当它对现有治疗不耐药时.
高耐火性焦点严重影响患者的生活质量,需要新的治疗策略.

研究的目的:

在常规的临床环境中,评估在患有高度耐火焦性的患者中赛诺巴的有效性和安全性.
评估现实世界的结果,包括保留率,发作减少和不良事件.

主要方法:

在西班牙三个临床中心进行了一项观察性,回顾性,第四期研究.
数据收集的重点是患者留守率,发作反应率 (50%的减少),发作自由度和治疗出现的不良事件 (TEAE).

主要成果:

在最后一次随访时,观察到高保留率为80.4%.
发作频率显著减少:在三个月后56.5%,在发作频率显著减少,在发作频率显著减少,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低,在发作频率显著降低.
塞诺巴马特的使用导致同时服用抗发作药物的数量减少,安全性概况可控,没有新的安全问题.

结论:

在标准临床实践中,雪诺巴在降低高度耐火性焦点患者的发作频率和强度方面表现出显著的有效性.
该药物表现出良好的保留率和可管理的安全性,支持其在该患者群体中的使用.

关键词:

抗发作药物抗发作药物基酸盐 (Cenobamate) 是一种焦点性 - 焦点性耐火性是一种耐药性.通道阻断剂是一种通道阻断剂.

更多相关视频

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

相关概念视频

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...